Species-Specific Humoral Immune Responses in Sheep and Goats upon Small Ruminant Lentivirus Infections Inversely Correlate with Protection against Virus Replication and Pathological Lesions.
Animals
Antibodies, Viral
/ immunology
Arthritis-Encephalitis Virus, Caprine
/ physiology
Female
Genotype
Goat Diseases
/ genetics
Goats
/ immunology
Immunity, Humoral
Lung
/ immunology
Mammary Glands, Animal
/ immunology
Pneumonia, Progressive Interstitial, of Sheep
/ genetics
Sheep
/ immunology
Species Specificity
Viral Load
/ immunology
Virus Replication
/ immunology
Visna-maedi virus
/ physiology
Caprine arthritis encephalitis virus (CAEV)
Maedi-Visna virus (MVV)
cytokines
immune response
pathogenesis
pepscan
small ruminant lentivirus (SRLV)
transmission
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Sep 2021
11 Sep 2021
Historique:
received:
04
08
2021
revised:
04
09
2021
accepted:
06
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
25
2
2023
Statut:
epublish
Résumé
Maedi-Visna-like genotype A strains and Caprine arthritis encephaltis-like genotype B strains are small ruminant lentiviruses (SRLV) which, for incompletely understood reasons, appear to be more virulent in sheep and goats, respectively. A 9-month in vivo infection experiment using Belgian genotype A and B SRLV strains showed that almost all homologous (genotype A in sheep; genotype B in goats) and heterologous (genotype A in goats; genotype B in sheep) intratracheal inoculations resulted in productive infection. No differences in viremia and time to seroconversion were observed between homologous and heterologous infections. Higher viral loads and more severe lesions in the mammary gland and lung were however detected at 9 months post homologous compared to heterologous infection which coincided with strongly increased IFN-γ mRNA expression levels upon homologous infection. Pepscan analysis revealed a strong antibody response against immune-dominant regions of the capsid and surface proteins upon homologous infection, which was absent after heterologous infection. These results inversely correlated with protection against virus replication in target organs and observed histopathological lesions, and thus require an in-depth evaluation of a potential role of antibody dependent enhancement in SRLV infection. Finally, no horizontal intra- and cross-species SRLV transmission to contact animals was detected.
Identifiants
pubmed: 34575988
pii: ijms22189824
doi: 10.3390/ijms22189824
pmc: PMC8467527
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : FOD Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu
ID : RF14/6289 SRLV-BEL
Références
Vet Microbiol. 2004 Jul 14;101(3):199-208
pubmed: 15223124
Bioinformatics. 2015 Jul 15;31(14):2374-6
pubmed: 25725497
Res Vet Sci. 2003 Dec;75(3):245-7
pubmed: 13129674
Bioinformatics. 2018 Aug 1;34(15):2666-2669
pubmed: 29547981
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Virology. 2006 Jun 20;350(1):116-27
pubmed: 16537085
Viruses. 2013 Aug 19;5(8):2043-61
pubmed: 23965529
Viruses. 2018 Dec 08;10(12):
pubmed: 30544780
Virology. 2007 Dec 5;369(1):119-30
pubmed: 17719071
J Virol Methods. 1992 Oct;40(1):85-93
pubmed: 1331162
Viruses. 2013 Jul 23;5(7):1867-84
pubmed: 23881276
Clin Vaccine Immunol. 2009 Apr;16(4):551-7
pubmed: 19261772
Vet Microbiol. 2015 Dec 14;181(1-2):75-89
pubmed: 26371852
Virus Res. 1999 Jun;61(2):177-83
pubmed: 10475088
Viruses. 2013 Aug 02;5(8):1948-63
pubmed: 23917352
J Virol. 2008 Feb;82(3):1526-36
pubmed: 18045935
Vet Res. 1998 May-Aug;29(3-4):341-67
pubmed: 9689746
Arch Virol. 1997;142(6):1125-37
pubmed: 9229003
Virology. 2004 Feb 5;319(1):12-26
pubmed: 14967484
Virology. 1996 Aug 1;222(1):21-30
pubmed: 8806484
Methods Mol Biol. 2018;1838:85-95
pubmed: 30128991
J Gen Virol. 2000 Dec;81(Pt 12):2929-2940
pubmed: 11086124
Vaccine. 2011 Jun 24;29(29-30):4794-804
pubmed: 21554913
Viruses. 2018 May 02;10(5):
pubmed: 29724026
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
J Virol Methods. 2004 Oct;121(1):73-8
pubmed: 15350735
J Gen Virol. 2013 Mar;94(Pt 3):634-642
pubmed: 23197577
Am J Vet Res. 1986 Mar;47(3):537-40
pubmed: 3008599
Genome Biol. 2007;8(2):R19
pubmed: 17291332
PLoS One. 2019 Feb 21;14(2):e0212585
pubmed: 30789950
J Virol. 1994 Nov;68(11):7139-47
pubmed: 7933096
J Virol Methods. 2013 Dec;194(1-2):250-7
pubmed: 24045043
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
Virology. 2016 Jan;487:50-8
pubmed: 26517396
Comp Immunol Microbiol Infect Dis. 2012 May;35(3):259-69
pubmed: 22237012
Vet Microbiol. 2009 Jul 2;138(1-2):156-62
pubmed: 19339126
J Virol. 1992 May;66(5):2679-88
pubmed: 1348546
Methods Mol Biol. 2014;1160:19-26
pubmed: 24740218
Virology. 2006 Aug 15;352(1):188-99
pubmed: 16716376
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
Viruses. 2013 Apr 23;5(4):1175-207
pubmed: 23611847
Sci Rep. 2018 Oct 29;8(1):15969
pubmed: 30374051
Vet Pathol. 1997 May;34(3):204-11
pubmed: 9163876
J Clin Microbiol. 2006 Mar;44(3):981-91
pubmed: 16517887
Am J Vet Res. 1983 Sep;44(9):1670-5
pubmed: 6625321
Clin Exp Immunol. 2002 Aug;129(2):240-6
pubmed: 12165079
Viruses. 2014 Aug 22;6(8):3311-33
pubmed: 25153344
Viruses. 2016 Jul 05;8(7):
pubmed: 27399757
Vet Microbiol. 2005 Apr 25;107(1-2):49-62
pubmed: 15795077
Nat Commun. 2016 Apr 15;7:11307
pubmed: 27079541
J Virol Methods. 2000 Apr;86(1):13-20
pubmed: 10713371
Virol J. 2014 Apr 03;11:65
pubmed: 24708706
PLoS One. 2020 Sep 10;15(9):e0238781
pubmed: 32911525
J Gen Virol. 1989 Aug;70 ( Pt 8):2221-6
pubmed: 2549189
Virology. 1967 Oct;33(2):250-61
pubmed: 6053142
Virus Genes. 2004 Oct;29(2):199-210
pubmed: 15284480
Lab Invest. 1976 Oct;35(4):402-12
pubmed: 185458
Vet Microbiol. 2013 Mar 23;162(2-4):572-581
pubmed: 23206411
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417
Curr HIV Res. 2010 Jan;8(1):94-100
pubmed: 20210785
Comp Immunol Microbiol Infect Dis. 2013 Jul;36(4):405-13
pubmed: 23582860
J Virol. 2000 Jul;74(13):6178-85
pubmed: 10846103
Virus Res. 2006 Sep;120(1-2):156-62
pubmed: 16616391
J Virol. 2017 Jan 3;91(2):
pubmed: 27852848
Vaccine. 2007 Sep 17;25(37-38):6713-20
pubmed: 17686553